AI lifestyle coaching vs. tirzepatide for weight loss in type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study compares two approaches to help adults with type 2 diabetes lose weight and keep it off: an AI personalized lifestyle program versus the medication tirzepatide. It aims to find which method works better for long-term weight maintenance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a BMI of 27 or higher.
- You have been diagnosed with type 2 diabetes within the last 5 years.
- You have not used insulin or medications that affect weight recently.
- You do not have certain serious health conditions like recent heart problems, pancreatitis, or certain thyroid issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares an AI-powered lifestyle coaching program with a medication called tirzepatide for people who are overweight or obese and have recently been diagnosed with type 2 diabetes. The goal is to see which approach is more effective in managing weight and blood sugar.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
This study looks at how well the medicine tirzepatide works in real life for adults who are overweight (BMI 30 or more) and have prediabetes or type 2 diabetes. It aims to see if the medicine helps control blood sugar and weight, and it's important that you have had a recent eye exam before starting.
This study tests a medication called tirzepatide for people with type 1 diabetes who also have overweight or obesity. Tirzepatide may help with weight loss and blood sugar control, and you'll use a continuous glucose monitor throughout the study.
This study tests a once-weekly medicine called tirzepatide to see if it helps control blood sugar and reduce weight in people with type 2 diabetes and obesity. If you qualify, you might get this treatment and be monitored for safety and satisfaction.
This trial compares two ways to manage weight: taking a GLP-1 medication (like tirzepatide or semaglutide) versus making lifestyle changes without medication. It will help researchers learn which approach works best for people with overweight or obesity.
Hear when a new Weight Loss Maintenance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.